drugset / Trial / NCT00708344
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the antihypertensive efficacy of the combination irbesartan/hydrochlorothiazide (HCTZ) using either a usual or an active elective titration regimen. The main efficacy criteria will be the change in mean Systolic Blood Pressure (SBP), measured at doctor's office with an automatic device, after a 10-week treatment period in hypertensive patients insufficiently controlled by monotherapy.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | — |
| Comparator | Irbesartan | Small molecule | 150 mg | — |
| Comparator | Irbesartan | Small molecule | 300 mg | — |